Uridine triacetate
Revision as of 23:14, 23 September 2019 by ClaireLewis (talk | contribs)
Administration
- Type: Antidote; Rescue Agent(Chemotherapy)
- Dosage Forms: Granule 10g
- Routes of Administration: Oral
- Common Trade Names: Vistogard
Adult Dosing
Fluorouracil or capecitabine toxicity
- 10g PO q6h x20 doses
- Give with soft food
Pediatric Dosing
Fluorouracil or capecitabine toxicity
- 1+ yr old
- 6.2 g/m^2 PO q6h x20 doses
- Give with soft food
- Max: 10g/dose
Special Populations
- Pregnancy Rating: C
- Lactation risk: Caution with use, weight risk/benefit
Renal Dosing
- Adult: Not defined
- Pediatric: Not defined
Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- May occur, but none reported
Common
Pharmacology
- Half-life: 2-2.5 hrs
- Metabolism: Tissue, prodrug converted to uridine
- Excretion: Urine
Mechanism of Action
- Incorporates into RNA, inhibiting cell damage and death caused by fluoruracil or capecitabine